Bottneuro AG

Bottneuro is revolutionizing Alzheimer's care with Miamind®, a personalized, non-invasive neurostimulation device for home use. Using MRI-based, 3D-printed caps, it delivers targeted transcranial electrical stimulation (tES) at gamma frequencies shown to improve cognition, reduce pTau levels, and slow disease progression. Registered in Switzerland and the UK as a custom-made device, Miamind® is already in use at several Swiss clinics. We aim to expand into Germany and the UK and are preparing for FDA/CE approval to scale globally.